Last updated: November 21, 2025
Sponsor: Muhammad Aamir Latif
Overall Status: Completed
Phase
N/A
Condition
Fungal Infections
Scalp Disorders
Treatment
Terbinafine
Itraconazole
Clinical Study ID
NCT07068256
DRSAIMA-JHLAHORE
Ages 1-13 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Any gender
Aged 1-13 years
With KOH mount positive before start of treatment
Duration of disease more than 1 month
Exclusion
Exclusion Criteria:
KOH mount negative before starting the treatment
Topical treatment with antifungal agents within past 4 weeks
Systemic treatment with antifungal agents within past 4 weeks
Patients with active liver disease
Patients with elevated liver enzymes
Study Design
Total Participants: 164
Treatment Group(s): 2
Primary Treatment: Terbinafine
Phase:
Study Start date:
April 01, 2025
Estimated Completion Date:
September 30, 2025
Study Description
Connect with a study center
Jinnah Hospital/Allama Iqbal Medical College
Lahore, Punjab 54700
PakistanSite Not Available
Jinnah Hospital/Allama Iqbal Medical College
Lahore 1172451, Punjab Province 1167710 54700
PakistanSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.